Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Codony-Servat J, Viteri S, Codony-Servat C, Ito M, Bracht JWP, Berenguer J, Chaib I, Molina-Vila MA, Karachaliou N, Rosell R.

Journal title: Transnational Lung Cancer Research

Journal number: August 8 (4)

Journal publisher: AME Publishing

Published year: 2019

DOI identifier: 10.21037/tlcr.2019.08.22

ISSN: 2226-4477